Lind Global Fund III LP - Sep 30, 2025 SCHEDULE 13G/A Report for Silexion Therapeutics Corp Ordinary shares, par value $0.0135 per share (SLXN)

Filing Manager
Lind Global Fund III LP
Reporting Manager
Lind Global Fund III LP
Security
Silexion Therapeutics Corp Ordinary shares, par value $0.0135 per share
Symbol
SLXN
Shares outstanding
3.32M shares
Disclosed Ownership
213K shares
Ownership
6.4%
Form type
SCHEDULE 13G/A
Date filed
11/14/2025, 04:09 PM
Date of event
Sep 30, 2025
Previous filing
Sep 18, 2025
SEC
View on sec.gov

Reporting Managers (3)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Lind Global Fund III LP 6.4% 213K 213K 0 By: Lind Global Partners III LLC, its General Partner, By: /s/ Jeff Easton Jeff Easton, Managing Member
Lind Global Partners III LLC 6.4% 213K 213K 0 /s/ Jeff Easton Jeff Easton, Managing Member
EASTON JEFF 6.4% 213K 213K 0 /s/ Jeff Easton Jeff Easton